- New
-
Topics
- All Categories
- Metaphysics and Epistemology
- Value Theory
- Science, Logic, and Mathematics
- Science, Logic, and Mathematics
- Logic and Philosophy of Logic
- Philosophy of Biology
- Philosophy of Cognitive Science
- Philosophy of Computing and Information
- Philosophy of Mathematics
- Philosophy of Physical Science
- Philosophy of Social Science
- Philosophy of Probability
- General Philosophy of Science
- Philosophy of Science, Misc
- History of Western Philosophy
- Philosophical Traditions
- Philosophy, Misc
- Other Academic Areas
- Journals
- Submit material
- More
Cancer clinical trial participants' assessment of risk and benefit
Connie M. Ulrich, Sarah J. Ratcliffe, Gwenyth R. Wallen, Qiuping Zhou, Kathleen Knafl & Christine Grady
AJOB Empirical Bioethics 7 (1):8-16 (2016)
Abstract
This article has no associated abstract. (fix it)Links
PhilArchive
External links
(no proxy)
Setup an account with your affiliations in order to access resources via your University's proxy server
Through your library
- Sign in / register and customize your OpenURL resolver
- Configure custom resolver
My notes
Similar books and articles
The evaluation of the risks and benefits of phase II cancer clinical trials by institutional review board (IRB) members: a case study.H. E. M. van Luijn - 2006 - Journal of Medical Ethics 32 (3):170-176.
Unrealistic optimism in early-phase oncology trials.Lynn A. Jansen, Paul S. Appelbaum, William Mp Klein, Neil D. Weinstein, William Cook, Jessica S. Fogel & Daniel P. Sulmasy - 2011 - IRB: Ethics & Human Research 33 (1):1.
An intervention to improve cancer patients' understanding of early-phase clinical trials.Nancy E. Kass, Jeremy Sugarman, Amy M. Medley, Linda A. Fogarty, Holly A. Taylor, Christopher K. Daugherty, Mark R. Emerson, Steven N. Goodman, Fay J. Hlubocky & Herbert I. Hurwitz - 2009 - IRB: Ethics & Human Research 31 (3):1.
Reasonable Risks In Clinical Research: A Critique and a Proposal for the Integrative Approach.Alex John London - unknown
Ethics and epistemology of accurate prediction in clinical research.Spencer Phillips Hey - 2015 - Journal of Medical Ethics 41 (7):559-562.
The social value of clinical research.Michelle Gjl Habets, Johannes Jm van Delden & AnneLien L. Bredenoord - 2014 - BMC Medical Ethics 15 (1):66.
Assessing research risks systematically: the net risks test.D. Wendler & F. G. Miller - 2007 - Journal of Medical Ethics 33 (8):481-486.
The Merits of Procedure-Level Risk-Benefit Assessment.Anna Westra & Inez de Beaufort - 2011 - IRB: Ethics & Human Research 33 (5):7-13.
Reciprocity‐Based Reasons for Benefiting Research Participants: Most Fail, the Most Plausible is Problematic.Neema Sofaer - 2013 - Bioethics 28 (9):456-471.
Off-trial access to experimental cancer agents for the terminally ill: balancing the needs of individuals and society.M. Chahal - 2010 - Journal of Medical Ethics 36 (6):367-370.
Evaluating the Risks and Benefits of Phase II and III Clinical Cancer Trials: A Look at Institutional Review Board Members in the Netherlands.H. van Luijn, A. Musschenga, R. Keus & N. Aaronson - 2007 - IRB: Ethics & Human Research 29 (1).
Taking part in a pharmacogenetic clinical trial: assessment of trial participants understanding of information disclosed during the informed consent process. [REVIEW]Diana Rose, Jasna Russo & Til Wykes - 2013 - BMC Medical Ethics 14 (1):34.
Undesirable implications of disclosing individual genetic results to research participants.Leslie Meltzer Henry - unknown
Benefits, risks and ethical considerations in translation of stem cell research to clinical applications in Parkinson's disease.Z. Master, M. McLeod & I. Mendez - 2007 - Journal of Medical Ethics 33 (3):169-173.
Analytics
Added to PP
2015-05-03
Downloads
49 (#323,230)
6 months
7 (#420,337)
2015-05-03
Downloads
49 (#323,230)
6 months
7 (#420,337)
Historical graph of downloads
Citations of this work
Informed Consent among Clinical Trial Participants with Different Cancer Diagnoses.Connie M. Ulrich, Sarah J. Ratcliffe, Camille J. Hochheimer, Qiuping Zhou, Liming Huang, Thomas Gordon, Kathleen Knafl, Therese Richmond, Marilyn M. Schapira, Victoria Miller, Jun J. Mao, Mary Naylor & Christine Grady - forthcoming - AJOB Empirical Bioethics.
Therapeutic Misperceptions in Early‐Phase Cancer Trials: From Categorical to Continuous.Bryan A. Sisk & Eric Kodish - 2018 - IRB: Ethics & Human Research 40 (4):13-20.
Cancer Clinical Trial Patient-Participants’ Perceptions about Provider Communication and Dropout Intentions.Qiuping Zhou, Sarah J. Ratcliffe, Christine Grady, Tianhao Wang, Jun J. Mao & Connie M. Ulrich - 2019 - AJOB Empirical Bioethics 10 (3):190-200.
Tissue vs Liquid Biopsies for Cancer Detection: Ethical Issues.Chiara Mannelli - 2019 - Journal of Bioethical Inquiry 16 (4):551-557.
Tissue vs Liquid Biopsies for Cancer Detection: Ethical Issues.Chiara Mannelli - 2019 - Journal of Bioethical Inquiry 16 (4):551-557.
References found in this work
Principles of biomedical ethics.Tom L. Beauchamp - 1994 - New York: Oxford University Press. Edited by James F. Childress.
Ethics and regulation of clinical research.Robert J. Levine - 1981 - Baltimore: Urban & Schwarzenberg.
Forced to be free? Increasing patient autonomy by constraining it.Neil Levy - 2014 - Journal of Medical Ethics 40 (5):293-300.
The future of bioethics: Three dogmas and a cup of hemlock.Angus Dawson - 2010 - Bioethics 24 (5):218-225.
Therapeutic Misconception in Clinical Research: Frequency and Risk Factors.Paul S. Appelbaum, Charles W. Lidz & Thomas Grisso - 2004 - IRB: Ethics & Human Research 26 (2):1.
PhilPapers logo by Andrea Andrews and Meghan Driscoll.
This site uses cookies and Google Analytics (see our terms & conditions for details regarding the privacy implications). Use of this site is subject to terms & conditions.
All rights reserved by The PhilPapers Foundation
Server: philpapers-web-64dd777598-zf4z4 uwo